Aim: Oxidized low-density lipoprotein (oxLDL) interacts with macrophages and is implicated in atherogenesis. Macrophages are also the major source within the atherosclerotic plaque of tissue factor (TF), the membrane-bound glycoprotein receptor that triggers the coagulation cascade in vivo and contributes to plaque thrombogenicity. In this study we tested the hypothesis that oxLDL modulates TF expression in human monocyte-derived macrophages (MDMs). 
Introduction
Low-density lipoprotein (LDL) and its oxidatively modified form (oxLDL) play an important role in the pathogenesis of atherosclerotic plaques 1, 2) . These frequently contain numerous macrophages instrumental in the oxidation and uptake of LDL 3, 4) through their scavenger receptor 5) . Macrophages can be induced to synthesize tissue factor (TF), a transmembrane cell-surface receptor and cofactor that initiates the coagulation cascade in vivo 6) . TF has been demonstrated in atherosclerotic lesions 7) and its content is even higher in unstable plaques [8] [9] [10] . Since macrophages that interact with oxLDL are also the major source of TF in the plaque 11) , it is plausible to hypothesize that oxLDL modulates TF expression by MDMs. The clinical significance of this interaction lies in its implications for the initiation of acute coronary syndromes precipitated by thrombosis that result from plaque disruption and exposure of lesion-associated TF to circulating blood.
Therefore, we sought to determine whether ox-LDL modulates TF procoagulant activity (TF-PCA) and TF protein expression in MDMs under both baseline condition and following stimulation with bacterial lipopolysaccharide (LPS), a known potent inducer of TF.
Methods

Reagents
Ficoll-Paque was obtained from Pharmacia Biotech AB (Uppsala, Sweden). LPS (Escherichia coli 0114: B4), leupeptin, aprotinin, pepstatin A, phenylmethylsulphonyl fluoride (PMSF), cupric sulphate, trichloroacetic and thiobarbituric acids, Tris-HCl, MgCl2, CaCl2, NP-40, orthovanadate, glycerol, -glycerophosphate, ethylenediaminetetracetic acid (EDTA), and pyrophosphate were purchased from Sigma Chemical Co. (St Louis, MO). RPMI-1640, penicillin, and streptomycin were obtained from Gibco BRL (Grand Island, NY). Fetal calf serum was from Omega Scientific Inc (Tarzana, CA). Native LDL was provided by Dr Mohamed Nawab, UCLA School of Medicine, Los Angeles.
Cells and culture
Mononuclear cells were isolated from concentrated human peripheral blood by density gradient centrifugation over Ficoll-Paque as described previously 12, 13) . Cells were washed and resuspended in RPMI-1640 (Gibco BRL) supplemented with 10% FCS, 100 U/mL penicillin, and 100 g/mL streptomycin. Cell viability was assessed by trypan blue exclusion. Mononuclear cell suspension (10 7 cells/mL) was incubated in tissue culture plates (Costar, Cambridge, MA) for 7 days at 37 and in a 5% CO2 humidified atmosphere. Cells in dishes were periodically washed, nonadherent cells were discarded and adherent cells replenished with RPMI-1640 as required, and after 7 days conditioned medium was replaced by BSA-supplemented serum-free medium. Twenty-four hours later, oxLDL (5-100 g/mL) or LPS (1 g/mL) were added according to the experimental design and cells further incubated for 24 hrs as described 13) . Positive staining for CD68 and TF, as well as morphological and functional (spreading) qualities observed after 7 days in culture characterized adherent cells as monocyte-derived macrophages 12, 13) . Disposable pyrogenfree labware was used exclusively and an aseptic technique employed during mononuclear cell isolation and culturing. The study was an investigator-initiated research approved by the local IRB.
Lipoprotein isolation and oxidation
Native low-density lipoprotein was isolated from plasma of normal subjects by density gradient ultracentrifugation according to Havel et al. 14) . Lipoproteins were expressed as g protein/mL of solution with protein concentration measured according to Bradford 15) . LDL was desalted by elution through a PD-10 disposable column (Sephadex ® G-25 M; Pharmacia Biotech), diluted to 500 g protein/mL, and oxidized overnight by incubation with 5 M copper sulfate at 37 in a 5% CO2 humidified atmosphere 16) .
Degree of LDL oxidation (TBARS)
Degree of LDL oxidation was quantitated by reference to malondialdehyde (MDA) content, which, according to Morel et al. 17) represents thiobarbituric acid-reacting substances (TBARS). In brief, 100 L lipoprotein suspension was incubated with 0.5 mL of 25% trichloroacetic acid and 0.5 mL of 1% thiobarbituric acid at 95 for 40 min. The mixture was then cooled, centrifuged at 1000 g for 30 min and a 200-L sample of the supernatant was read in a plate reader at 540 nm. Optical density was converted to equivalent MDA units that reflect TBARS using a standard curve constructed with malondialdehyde bis (dimethyl acetate)(1,1,3,3,-tetramethoxy-propane, Aldrich, Milwaukee, WI), freshly dissolved in saline and serially diluted. Endotoxin levels in oxLDL were measured by E-toxate (LAL-Limulus amebocyte lysate; Sigma).
Tissue factor procoagulant activity
Cells were harvested by gentle scraping with a rubber policeman (Fisher Scientific), and cell counts were performed with Technicon H-3 System (Miles, Tarrytown, NY). TF-PCA of cells was quantified by a one-stage recalcification clotting time as described 18) . Briefly, 50 L pooled normal platelet-poor plasma was mixed with 50 L cellular suspension. After incubation at 37 for 170 s, 50 L of 25-mM calcium chloride at 37 was added and clotting time was measured by an ST4 clot-timer (Diagnostica Stago, Asnières, France). A standard curve was constructed with recombinant hTF (OrthoDiagnostics Systems, Raritan, NJ) for each experiment. Results shown are the average of replicate data (n 2-3) from independent measurements and expressed as ng rhTF/10 6 cells. The intra-assay variability was 2-5% (r 0.98). TF-PCA values were normalized relative to control samples since cells utilized in each experiment were obtained from a single donor, isolated in one batch, and therefore identical. Assay specificity for TF was validated by experiments in which 1.5 g monoclonal anti-TF antibody cocktail containing monoclonal antibodies TF8-5G9, TF9-6B4, and TF9-9C3 19) was added to the sample and shown to inhibit clotting (data not shown). This was done by mixing 50 L of anti-TF antibody cocktail with cell suspension and plasma, and after brief incubation, proceeding as usual by adding CaCl2. Control samples in which normal saline replaced the anti-TF mixture were assayed for each inhibitory run to account for the dilution effect.
Western blot analysis
For Western blot analysis, cells were harvested by gentle scraping and immediately sedimented. Cell pellets were lysed at room temperature with lysis buffer as described 20) . Samples were then sonicated by 30 icechilled 1-sec medium-intensity bursts with a model 60 Sonic Dismembrator (Fisher Scientific, Pittsburgh, PA). Samples were spun down, the supernatant aliquoted, and stored at 75 . Protein concentration was determined according to Bradford 15) utilizing Coomassie blue brilliant blue G-250 (Bio-Rad Labs, Richmond, CA).
Immunoblotting of TF protein was performed using monoclonal anti-TF antibody cocktail 19) . Thawed lysates were boiled for 5 min in sample buffer, and 20 g protein or hrTF sample (as a positive control) loaded and electrophoresed in 12% Tris/ glycine SDS-PAGE gel (Hoefer Scientific Instrumentation, San Francisco, CA). Samples were transferred to nitrocellulose (NICEL RL, Hoefer Scientific Instruments) using a Trans-blot SD transfer cell (Bio-Rad Laboratories). Blots were blocked overnight at 4 with a 1% blocking solution (1% powdered milk in 0.1% Tween-PBS solution), and incubated while gently shaken for 1 hour at room temperature with 1 g/mL anti-TF antibody. Blots were washed 4 times while rocking gently and incubated similarly with a 1:700 dilution of horseradish peroxidase-conjugated antimouse IgG (Oncogene Science Inc.) for 1 hour at room temperature. Membranes were then washed 4 times with washing buffer, blots recorded utilizing the enhanced chemiluminescence detection system (ECL, Amersham, UK) and exposed to X-OMAT TM AR film (Eastmen-Kodak, Rochester, NY). Blots were quantitated by computer-analyzed densitometry (UVGel version 2.0, UVP Inc., Upland, CA).
Northern blot analysis
hTF cDNA probe preparation The human TF cDNA probe was a 641 bp EcoRI fragment from clone c TF2 subcloned into pUC8 21) . The 641-bp TF cDNA fragment was isolated from pUC8 by digestion with EcoRI and electrophoresis on a 1% agarose gel. The hTF cDNA specific band was cut, frozen at 20 , and subsequently separated by centrifugation to yield hTF cDNA in the supernatant. The size of the hTF cDNA was verified by reference to a standard DNA ladder.
RNA extraction and gel electrophoresis Mononuclear cells (10 7 cells/dish) were maintained in culture dishes (Baxter, McGraw Park, IL) for 7 days and were serum-starved for 24 hours before stimulation. Total RNA was extracted with TRIzol ® (Gibco BRL, Grand Island, NY) by the single-step method 22) . RNA sample (20 g) was separated on 1% agarose-formaldehyde (37%) gel, transferred overnight by capillary blotting with 20xSSC (3 M NaCl, 0.3 M sodium citrate, pH 7.0) onto nylon membrane (ICN Biotrans, Irvine, CA), and crosslinked with ultraviolet light. hTF cDNA (20 ng) was labeled with 32 P-dCTP (3000 Ci/mmol; NEN, Boston, MA) by the random primer method (Prime-It ; Stratagene, La Jolla, CA) and passed through a Nick column (Pharmacia Biotech) to remove unincorporated dCTP, yielding specific activity 10 9 cpm/ g. Blots were prehybridized in hybridization solution (0.5 M sodium phosphate buffer [0.35 M Na2HPO4, 0.15 M NaH2PO4], 1 mM EDTA, 1% BSA, 7% sodium dodecyl sulfate [SDS]) for 1 hour at 65 , then hybridized with the probe at 1-2 10 6 cpm/ mL overnight at 65 , and washed in wash mix (40 mM sodium phosphate buffer [28 mM Na2HPO4, 12 mM NaH2PO4], 1 mM EDTA, 1%SDS) at 65 . Finally, blots were exposed to X-OMAT AR film (EastmanKodak) with intensifying screens at 75 .
Flow-cytometry
Flow-cytometry was used to measure the percentage of cells expressing membrane TF antigen beyond a specified fluorescence threshold determined in a negative isotype control sample. Cells were incubated on ice with 1 g monoclonal anti-TF antibody or irrelevant IgG1 per sample. Specimens were washed in PBS-FCS and centrifuged at 300g. After aspirating the supernatant, sedimented cells were incubated in the dark with FITC-conjugated goat anti-mouse antibody (Becton-Dickinson, San Jose, CA). Cells were washed again, resuspended in cold 2% paraformaldehyde, and analyzed. Gating was based on the resulting distribution of cells of monocyte lineage as displayed by CD14 detection.
Statistical analysis
Variables are expressed as the mean standard deviation. Statistical significance of differences was determined by applying unpaired t-test or one-way ANOVA for multiple comparisons where appropriate. A p value 0.05 was considered statistically significant.
Results
Cell isolation
After isolation, mononuclear cell suspension contained on average 82% lymphocytes, 15% monocytes, and 2-3% polymorphonuclear leukocytes as determined by microscopic examination of smears, and 1 platelet/leukocyte according to cell count. Trypan blue dye exclusion test demonstrated cell viability in the range of 94%-96%. After 8 days in culture (in serumfree medium for last day of culture) 97% of cells were MDMs.
Degree of LDL oxidation
The extent of lipoprotein oxidation as assessed by TBARS concentration was 3.3 0.9 and 16.5 6.3 nmoles MDA/mg LDL protein for native LDL and oxLDL, respectively. These results show that exposure to cupric sulfate for 16 hours yielded moderately oxidized LDL, whereas the unoxidized native LDL contained TBARS comparable to that defined as minimally modified LDL 23) . This may be due to minimal oxidation throughout storage and handling, or to the baseline degree of oxidation. Minimal endotoxin levels of 5-50 picogram/ml were measured in the experiments depending on oxLDL concentration (at 0.1 ng endotoxin/mg oxLDL).
TF-Procoagulant Activity
Initially, we evaluated the effect of 24-hr co-incubation of LDL or oxLDL (both 100 g/mL) with MDMs on TF expression and found a significant decrease from the control level in both. In these preliminary experiments, normalized LDL-induced TF-PCA decreased to 0.7 0.3 (n 16, p 0.01 compared with the control), whereas oxLDL decreased to 0.6 0.3 ( p 0.01). LDL yielded similar though slightly erratic results, possibly due to partial processing-induced oxidation, and since oxLDL is the clinically-relevant pathologic mediator of atherosclerosis, we carried out all further experiments with oxLDL. The dose response of TF-PCA to oxLDL concentration in MDMs is shown in Fig. 1 , which depicts 4 consecutive doseresponse experiments. Low-concentration (5-10 g/ mL) oxLDL increased TF-PCA in MDMs, whereas higher oxLDL concentrations (20-100 g/mL) suppressed TF-PCA. High-concentration oxLDL (100 g/mL) attenuated control ( Fig. 1) as well as LPSstimulated TF-PCA in MDMs at 24 hrs (Table 1) , whereas no statistically significant effect was discerned at 4 hrs (data not shown). A 24-hr exposure reduced normalized TF-PCA by 30% ( p 0.01, Table 1 ). Stimulation of MDMs by LPS for 24 hours increased normalized TF-PCA 3-fold, while co-incubation with oxLDL attenuated this response by 47% ( p 0.01). Cell viability following incubation with oxLDL was 96% by trypan blue exclusion test at all concentrations.
Cellular TF protein content
The changes of TF protein content in MDMs after incubation with oxLDL were evaluated by Western blot analysis, and quantitated for comparison by computer-assisted densitometry. Fig. 2A displays a Western blot showing the typical TF protein dose response to oxLDL while Fig. 2B depicts the averaged normalized TF protein dose response (n 6, p 0.03). Incubation of MDMs with 5 g/mL oxLDL increased TF protein compared to the control by 31%, while co-in- cubation with 50 and 100 g/mL oxLDL suppressed TF protein content by 34% and 32%, respectively ( p 0.03). Significant augmentation of TF protein was observed after stimulation with LPS, an effect attenuated by 100 g/mL oxLDL. Averaging Western blot results after densitometric analysis and normalization demonstrated that LPS increased TF protein 6-fold to 7.0 4.4 ( p 0.017), whereas 100 g/mL of oxLDL significantly attenuated this response to 3.7 3.3 fold control ( p 0.01), respectively (Fig. 3) .
TF mRNA expression
hTF mRNA was evaluated by Northern blotting 4 hours after the addition of oxLDL. Low-concentration oxLDL (5-10 g/mL) increased TF mRNA about 2-fold. At higher concentrations of oxLDL (50-100 g/mL) mRNA was decreased 2-and 2.5-fold, respectively ( p 0.04, Fig. 4 ).
Membrane-associated TF antigen
Flow-cytometry was performed in MDMs after 24 hours of stimulation and the results are shown in Fig. 5 . LPS was not found to increase significantly the percentage of TF-positive MDMs expressing intensity beyond the negative control sample; however, 100 g/ mL oxLDL, whether with or without LPS, decreased the percentage of TF-positive gated cells in a pattern similar to the effects noted for TF-PCA (Fig. 1, Table  1 ) or TF protein (Fig. 2, 3) . A representative experiment performed for the dose response of TF protein to co-incubation with oxLDL, as evaluated by Western blotting (A). Averaged TF protein dose response to oxLDL by Western blotting after densitometric analysis and normalization (B, n 6), demonstrating the same pattern as obtained for TF-PCA dose response after exposure to different oxLDL concentrations. Peak expression was observed at 5 mg/mL oxLDL and suppressed thereafter ( p 0.03 for trend).
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Discussion
OxLDL is strongly implicated in the etiology of atherogenesis through its interaction with lesion-resident monocytes and macrophages 1, 2) . These cells that modify LDL and take up the resulting oxLDL through their scavenger receptor 5) are also the primary source of TF in plaques 11) ; however, the effect of ox-LDL on TF expression by macrophages, shown to express markedly higher TF levels than monocytes 12) , has not been delineated. Schwartz et al. 24) found that high-concentration LDL actively suppressed the generation of procoagulant activity in human peripheral blood mononuclear cells after 6-hour incubation, similar to our finding with both native LDL and ox LDL (both at 100 g/mL). Brand et al. 25) found that ox-LDL alone did not induce TF expression in human adherent monocytes but it significantly enhanced LPS-induced TF-PCA in these cells. LPS, as well as other cytokines, known to be present within the active atherosclerotic lesion, activates these cells by an autocrine mechanism 26) and may further induce TF biosynthesis in monocytes and MDMs 12, 27) . We have observed in the present study a bimodal effect of oxLDL on TF expression in human monocyte-derived macrophages. It was demonstrated that co-incubation of MDMs with low-concentration ox-LDL (5-10 g/mL) for 24 hours enhanced TF-PCA expression, while higher oxLDL concentration g/mL) inhibited the expression of TF-PCA and TF protein. Furthermore, a higher concentration of ox-LDL (100 g/mL) attenuated even the LPS-stimulated increase of TF-PCA and TF protein expressed by these cells under the same conditions. Such oxLDL concentration was chosen since it is commonly used in many studies, and it seems to approximate the extra-cellular concentration of apoB 28) , which is the major protein component of LDL. Of note, the dose-dependent changes in TF-PCA and TF protein observed at 24-h paralleled the pattern of corresponding mRNA levels obtained at 4 hrs, at which time no significant effect of oxLDL on TF-PCA and TF protein was detected. Whether the present findings apply to atherosclerotic plaque at different stages of its evolution is difficult to determine at present. Theoretically, it may imply higher thrombogenic potential within the nascent plaque at the initial stage of development.
de Winther et al. argue, regarding the bimodal effect of oxLDL on TF expression in human MDMs, that short-term incubation or low concentrations of oxidized LDL can enhance NF-B activation in monocytes while longer incubations and usage of highly oxidized LDL have been shown by many groups to inhibit NF-B-mediated inflammatory responses in monocytes and macrophages 29) . Robbesyn et al. have also emphasized the dual effect of oxLDL on the NF-B system 30) . These are in accord with Brand et al. 31) and the present finding of a bimodal oxLDL concentration-dependent TF expression. Indeed, in this study and another reported elsewhere 13) , we have found by an electromobility shift assay that 2 hours after exposure to higher-concentration oxLDL ( 20 g/mL) the nuclear content of NF-B was decreased. This could account for the observed decrement in TF mRNA at 4 hours (Fig. 4) and the reduction in TF protein and TF-PCA 24 hours after initiation of co-incubation with oxLDL.
OxLDL was previously reported to inhibit LPSstimulated mRNA expression of interleukin (IL)-1 32) and suppressed the expression of tumor necrosis factor (TNF ) mRNA in stimulated peritoneal macrophages 33) . As previously mentioned, these cytokines trigger TF expression; therefore, it is feasible that ox-LDL indirectly inhibits TF biosynthesis under conditions that suppress the synthesis of these cytokines. However, the direct mechanism by which higher-concentration oxLDL suppresses TF-PCA and TF protein in MDMs after 24-hour or longer exposure is putatively mediated through the nuclear factor-kappaB (NF-B) pathway, whose activation is central in the transcriptional regulation of TF expression in monocytic cells 34) . It has been reported that oxLDL at concentrations comparable to those used in our study suppressed NF-B activation in macrophages exposed to oxLDL via a pertussis toxin-sensitive mechanism 35) . Recently, Weisner et al. examined the cooperative activation of macrophages by low levels of LPS and by minimally oxLDL 36) . They did not examine TF, but evaluated the response of dual-stimulated macrophages to express proinflammatory cytokines, as a model for subclinical endotoxemia-induced atherosclerosis. Minimally oxLDL and LPS cooperative effects were evident at threshold LPS concentration (1 ng/mL) at which LPS alone induced only a limited macrophage response. These reseachers concluded that the cooperative engagement of AP-1 and NF-B by minimal oxLDL and LPS may constitute a mechanism by which increased transcription of inflammatory cytokines occurs within atherosclerotic lesions. This reported synergistic effect between oxLDL and LPS contrasts with the present findings but can be reconciled with our results by noting the low concentrations utilized by Wiesner at al.
The effect of LDL-associated tissue factor pathway inhibitor (TFPI) as an alternative explanation for the observed TF-PCA suppression seems unlikely. TFPI is a protease inhibitor that regulates TF-mediated coagulation by binding factor Xa and inactivating TF VII 37) . Most of TFPI activity in plasma is associated with lipoproteins where 40-80% of its activity is transported by apoB-containing particles, largely by LDL; however, cell-and copper-mediated oxidation, even when resulting in a low-oxidized product such as minimally modified LDL, significantly inactivated TFPI activity and neutralized its inhibitory influence on TF-PCA 38) . In addition, if TFPI-inhibited TF-PCA was truly the mechanism underlying the effect of higher-concentration oxLDL, then LPS-stimulated TF-PCA could not have been attenuated to the extent observed, and TF protein expression evaluated by Western blotting would not have shown the pattern demonstrated. In other experiments evaluating the effect of the combination of LPS and LDL on TF expression by MDMs we realized that LDL had a marginal effect on TF-PCA suppression in these cells whereas LPS oxLDL inhibited this activity markedly.
In summary, exposure of MDMs to low-concentration oxLDL (5-10 g/mL) for 24 hours enhanced TF expression while co-incubation with higher concentrations (20-100 g/mL) was found to decrease both control as well as LPS-stimulated TF-PCA. The latter finding was corroborated by the results of Western blot analysis and flow-cytometry. This phenomenon may represent the changing conditions prevailing within atherosclerotic plaque during different stages of its evolution. In the initial phases of lesion development when lipid accumulates insidiously, the microenvironment conditions may favor TF expression, thus augmenting plaque lipid-core thrombogenicity. At a later stage of plaque evolution when extracellular lipid and oxLDL abound, TF-PCA may be partially attenuated, resulting in reduced thrombogenic potential.
